Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine for euthyroid women with recurrent miscarriage and thyroid autoimmunity
2011-001820-39Phase 3Terminated
- Sponsor
- Amsterdam University Medical Center
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in recurrent miscarriage (RPL), autoimmune thyroid disease (AITD) and preterm birth comparing Levothyroxine supplementation with Placebo or no levothyroxine (2 arms). Primary endpoint: Live birth rate. Started Dec 2012; status: terminated.
02
Drugs
levothyroxine sodium
03
Conditions
recurrent miscarriage (RPL)autoimmune thyroid disease (AITD)preterm birth
Beyond the preview
Go deeper on 2011-001820-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001820-39.